Table 2.

Rate of appearance of new cells k (%/day)

Patient	Disease	Day 13* ALC (×103/μL)	13* PB k	13* LN k	13* BM k	28* PB k	35* PB k
HW01	CLL	243	0.42	1.65	0.42	0.42	0.38
HW02	SLL	3	-	1.27	-	-	-
HW03	CLL	37	0.62	-	0.23	0.79	0.79
HW04	CLL	163	1.66	2.92	0.96	1.69	-
HW05	CLL	20	0.08	-	0.18	0.11	0.11
HW06	CLL	142	0.48	1.24	-	0.53	-
HW07	SLL	2	2.11	0.91	0.50	2.04	-
HW08	CLL	116	1.12	1.37	0.76	0.97	-
HW09	CLL	75	0.34	0.82	-	0.49	0.47
HW11	CLL	30	0.12	0.42	0.51	0.14	0.14
HW12	SLL	4	0.49	0.88	0.74	0.36	0.31
HW13	CLL	13	0.68	1.00	-	0.64	0.52
HW15	CLL	23	1.42	1.56	-	0.92	1.36
HW18	CLL	33	0.5	1.44	-	-	-
HW20	CLL	101	1.74	3.32	-	-	-

^*±2 days; ALC, Absolute lymphocyte count;

PB, Peripheral blood; BM, Bone marrow; LN, Lymph node

6 patients provided PB, LN, and BM; 6 patients provided PB and LN; 2 patients provided PB and BM and in one patient only the LN sample could be analyzed.